Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: Data from CaPSURE

Journal of Clinical Oncology

Volumn 28, Issue 6, 2010, Pages 1069-1074

  Moses, Kelvin A ^a   Paciorek, Alan T ^a   Penson, David F ^a   Carroll, Peter R ^a   Master, Viraj A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; ATTITUDE TO HEALTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER THERAPY; COMORBIDITY; CONTROLLED STUDY; DATA BASE; EDUCATIONAL STATUS; ETHNICITY; EUROPEAN AMERICAN; HAZARD RATIO; HEALTH CARE FACILITY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT EDUCATION; PERCEPTION; PRIORITY JOURNAL; PROSTATE CANCER; BRACHYTHERAPY; CANCER STAGING; CAUCASIAN; ETHNOLOGY; FOLLOW UP; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIANDROGEN;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77949905855     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.2469     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Hu JC, Kwan L, Krupski TL, et al: Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology 72:1274-1279, 2008
3. Kawakami J, Cowan JE, Elkin EP, et al: Androgen-deprivation therapy as primary treatment for localized prostate cancer: Data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer 106:1708-1714, 2006
4. Schapira MM, McAuliffe TL, Nattinger AB: Treatment of localized prostate cancer in African-American compared with white men: Less use of aggressive therapy for comparable disease. Med Care 33:1079-1088, 1995
5. Zeliadt SB, Ramsey SD, Penson DF, et al: Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer. Cancer 106:1865-1874, 2006
6. DeLancey JO, Thun MJ, Jemal A, et al: Recent trends in Black-white disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev 17:2908-2912, 2008
7. Underwood W, De Monner S, Ubel P, et al: Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 171:1504-1507, 2004 (Pubitemid 38365406)
8. Zeliadt SB, Potosky AL, Etzioni R, et al: Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology 64:1171-1176, 2004
9. Pettaway CA, Troncoso P, Ramirez EI, et al: Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens. J Urol 160:437-442, 1998 (Pubitemid 29476693)
10. Bach PB, Schrag D, Brawley OW, et al: Survival of blacks and whites after a cancer diagnosis. JAMA 287:2106-2113, 2002 (Pubitemid 34437345)
11. Gaston KE, Kim D, Singh S, et al: Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 170:990-993, 2003 (Pubitemid 36999618)
12. Hoffman RM, Harlan LC, Klabunde CN, et al: Racial differences in initial treatment for clinically localized prostate cancer: Results from the prostate cancer outcomes study. J Gen Intern Med 18:845-853, 2003 (Pubitemid 37281780)
13. Tewari AK, Gold HT, Demers RY, et al: Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology 73:624-630, 2009
14. Jones BA, Liu WL, Araujo AB, et al: Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 17: 2825-2834, 2008
15. Latini DM, Elkin EP, Cooperberg MR, et al: Differences in clinical characteristics and disease-free survival for Latino, African American, and non- Latino white men with localized prostate cancer: Data from CaPSURE. Cancer 106:789-795, 2006
16. Powell IJ, Banerjee M, Bianco FJ, et al: The effect of race/ethnicity on prostate cancer treatment outcome is conditional: A review of Wayne State University data. J Urol 171:1508-1512, 2004 (Pubitemid 38365407)
17. deVere white RW, Deitch AD, Jackson AG, et al: Racial differences in clinically localized prostate cancers of black and white men. J Urol 159:1979-1982, 1998; discussion 1982-1983
18. Bangsi D, Zhou J, Sun Y, et al: Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. Urol Oncol 24:21-27, 2006 (Pubitemid 43097351)
19. Powell IJ: Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 177:444-449, 2007
20. Harlan LC, Potosky A, Gilliland FD, et al: Factors associated with initial therapy for clinically localized prostate cancer: Prostate cancer outcomes study. J Natl Cancer Inst 93:1864-1871, 2001
21. Wong YN, Freedland SJ, Egleston B, et al: The role of primary androgen deprivation therapy in localized prostate cancer. Eur Urol 56:609-616, 2009
22. Schwandt A, Garcia JA: Complications of androgen deprivation therapy in prostate cancer. Curr Opin Urol 19:322-326, 2009
23. Underwood W 3rd, Wei J, Rubin MA, et al: Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urol Oncol 22:20-24, 2004 (Pubitemid 38542708)
24. Powell IJ, Heilbrun L, Littrup PL, et al: Outcome of African American men screened for prostate cancer: The Detroit Education and Early Detection Study. J Urol 158:146-149, 1997 (Pubitemid 27251612)